Mechanisms of Change with Early Intervention in Tuberous Sclerosis Complex

Information

  • Research Project
  • 10461690
  • ApplicationId
    10461690
  • Core Project Number
    R01HD090138
  • Full Project Number
    7R01HD090138-06
  • Serial Number
    090138
  • FOA Number
    PA-21-268
  • Sub Project Id
  • Project Start Date
    7/1/2017 - 7 years ago
  • Project End Date
    3/31/2023 - a year ago
  • Program Officer Name
    KING, TRACY
  • Budget Start Date
    8/5/2021 - 3 years ago
  • Budget End Date
    3/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    06
  • Suffix
  • Award Notice Date
    8/27/2021 - 3 years ago

Mechanisms of Change with Early Intervention in Tuberous Sclerosis Complex

PROJECT SUMMARY/ABSTRACT Background: Children with Tuberous Sclerosis Complex (TSC) are at high risk for neurodevelopmental disorders, with rates of autism spectrum disorder (ASD) approaching 60%. Prospective studies have found that infants with TSC demonstrate delays in social communication skills in the first year of life. However, to date no studies have investigated whether early behavioral intervention can improve social communication skills in infants with TSC. Objectives: The overarching goal of the study is to determine if social communication function can be improved in infants with TSC with a targeted, short-term behavioral intervention called JASPER (Joint Attention, Symbolic Play, Engagement, Regulation), and to enrich traditional outcome measures by combining behavioral measures with electrophysiological (EEG) biomarkers of social communication. These biomarkers can capture subtle changes in brain development that may reflect responses to treatment prior to an overt behavioral change, particularly relevant for children with significantly delayed development, and they can inform the neural mechanisms underlying the behavioral changes found with intervention. Hypothesis: It is expected that, compared to a wait list control group, infants receiving the JASPER intervention will demonstrate greater gains in social communication skills, with changes captured both behaviorally and electrophysiologically. Methodology: A total of 60 infants with TSC ages 12-36 months will be recruited across two sites with an established collaboration in TSC research, UCLA and Boston Children's Hospital, with each infant randomized to treatment or wait list control group. The wait list control design allows all infants to receive intervention while still maintaining a non-treatment comparison group. Treatment will consist of 12 weeks of weekly intervention sessions. Assessments (clinical, behavioral and EEG) will be performed before treatment, after treatment, 3 months after completion, and then 12 months after completion. Controls will undergo assessments at the same time points, and then will start intervention at month 6. Assessments will include behavioral measures of social communication skills, cognition, language and adaptive function, and EEG measure of resting state brain activity, visual and face processing. Impact: Early intervention improves cognitive and behavioral outcomes in ASD, yet no studies have investigated the effects of targeted, early behavioral intervention in infants with TSC. Evidence of efficacy of early intervention will justify its value for all infants with TSC, improving developmental outcomes and attenuating symptoms that lead to the diagnosis of neurodevelopmental disabilities in TSC. Moreover, this study holds relevance for intervention research across neurodevelopmental disorders through its integration of EEG biomarkers with behavioral measures, as such methodology may more readily capture the effects of treatment in pre-verbal and developmentally delayed infants.

IC Name
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT
  • Activity
    R01
  • Administering IC
    HD
  • Application Type
    7
  • Direct Cost Amount
    198551
  • Indirect Cost Amount
    47777
  • Total Cost
    246328
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    865
  • Ed Inst. Type
  • Funding ICs
    NICHD:246328\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    CPDD
  • Study Section Name
    Child Psychopathology and Developmental Disabilities Study Section
  • Organization Name
    CHILDREN'S HOSPITAL OF LOS ANGELES
  • Organization Department
  • Organization DUNS
    052277936
  • Organization City
    LOS ANGELES
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    900276062
  • Organization District
    UNITED STATES